The Science of Medical Cannabis
In this course, the long history of cannabis for medicinal uses along with recent research demonstrating the science behind the health benefits are discussed.
Donald Abrams, MD
Board Review Series
AIHM 2016 Annual Conference
Time to Complete
What you will learn
The U.S. government classifies cannabis—along with heroin and LSD—as a Schedule I drug, the most tightly restricted category of drugs in the United States. According to the federal government, Schedule I drugs are unsafe and have "no currently accepted medical use in treatment in the United States.” However, as medical cannabis proponents have pointed out since the Controlled Substances Act was passed by Congress in 1970, cannabis has been used medicinally for thousands of years, and there has never been a reported case of a marijuana overdose. Moreover, in recent years clinical researchers around the world have demonstrated the medicinal value of cannabis.By the end of this course, learners will be able to:
- Examine the classification of cannabis and the implications for that on research including the “Controlled Substances Act”.
- Review the uses of cannabis as a medicine and clinically researched protocols, uses of medicinal marijuana including dosing, etc.
- Describe the effectiveness of cannabis for the use in peripheral neuropathy, chronic pain, HIV and other illnesses.
- Discuss the biochemical pathways, CB1 & CB2 receptors and cannabinoid chemicals naturally found in the body and their biological actions.
Certificate of Completion
Included in this course
Donald Abrams, MD
Donald Abrams, M.D. is chief of Hematology and Oncology at Zuckerberg San Francisco General and has an integrative oncology consultative practice at the University of California San Francisco Osher Center for Integrative Medicine. He is a professor of Clinical Medicine at UCSF. He co-edited with Andrew Weil the Oxford University Press text Integrative Oncology. Abrams has extensive experience working with cancer and HIV/AIDS patients and is a pioneer in the field of medical cannabis research.
The CME for this course has expired, however you will continue to have access to your purchased content.
This course is self-paced with no set beginning or end date. You may complete this course on your own schedule and pace. Enrolling in and purchasing this course grants you access to its contents in perpetuity.